1Edwards JE, Bodey GP, Bowden RA, et al .International conference for the development of a consenus on the management and prevention of severe candidal infectious[J].Clin Infect Dis,1997,25:43 - 59.
3National Committee for Clinical Laboratory Standards .Method for antifungal disk diffusion susceptibility testing of yeasts; proposed guideline[S]. NCCLS M44-P,2003,123:6.
4Ptaller MA, Jones RV, Doem GV, et al. Bloodstream infectious due to candida peeies: SENTRY antimicrobial surveillance program in North America and Latin America[J].Antimicrob Agents Chemother,2000,44: 747 - 751.
5Edmond MB, Wallace SE, McClish Dk, et al. Nosccomial bloodstream infections in United States Hospitals: a three-year analysis[J]. Clin Infeet Dis,1999,29:239 - 244.
1Edwards JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infectious[J]. Clin Infect Dis, 1997,25:43-59.
2National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility of yeast ; Approved standard M27A[ S]. Lancaster Avenue, villanova, pennsylvania: NCCLS, 1997.1-12.
3Ptaller MA, Jones RV, Doern GV, et al. Bloodstream infectious due to candida species: SENTRY antimicrobial surveillance program in North America and Latin America[ J ]. Antimicrob Agents Chemother, 2000,44 :747-751.
4Schwab U, Chemomas F, Larcom L, et al. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients [J ]. Diag Microbiol Infect Dis, 1997,29 : 11-17.
6Nation committee for clinical laboratory standards reference method for broth dilition antigungal susceptibility testing of yeasts tentative standards [ S ]. Document M27-T. Wayne Pensylvania: NCCLS, 1995,15 : 1 - 22.
7Nation committee for clinical laboratory standards method for antifungal disk diffusion susceptibility testing of yeasts:proposed guideline M44-p[ S]. Wayne Pensyloania: NCCLS ,2003:23.
